Skip to content

Be Well Memory: add-on acquisition by Frazier Healthcare Partners

Add-on acquisitionbuyer Frazier Healthcare Partners

LUX Infusion Acquires Be Well Memory and Infusion's Specialty Infusion Business

Announced
Nov 3, 2026
announcedadd-onFact

16 additional comparable deals, 1 additional named party

Every relationship, signal and contact on this record, with the source on each.

What happened

Platform
LUX Infusionadd-on basis: LUX Infusion is a portfolio company of Frazier Healthcare Partners.
Control
Control
Share acquired
unknown
Industry
healthcare / infusion
Target location
unknown
Seller kind
unknown
Rollover
unknown

Values and comparable deals

No value was disclosed for this deal: no enterprise value, price, equity value, revenue, EBITDA or multiple.

Observed exact comps
  • Suite HealthAdd-on acquisition in healthcare services, COannounced Oct 15, 2026Not disclosed
    Similar because: same sector (healthcare services), same niche (infusion), same kind of deal (add-on acquisition), both control deals, 1 month apart
  • Two Ambulatory Infusion CentersAdd-on acquisition in healthcare servicesannounced Sep 11, 2026Not disclosed
    Similar because: same sector (healthcare services), same niche (infusion), same kind of deal (add-on acquisition), both control deals, 2 months apart
  • Infusion Care AssetsAdd-on acquisition in healthcare servicesannounced May 19, 2025Not disclosed
    Similar because: same sector (healthcare services), same niche (infusion), same kind of deal (add-on acquisition), both control deals, 18 months apart

16 more comparables open with the complete profile.

Values print only where a source disclosed them; no multiple or price is estimated. No location or disclosed value is on this record, so the match could not use them.

Parties and roles

4 named
Buy side
  • LUX InfusionPlatformconfirmed
    “LUX Infusion is a portfolio company of Frazier Healthcare Partners.”
  • “LUX Infusion is a portfolio company of Frazier Healthcare Partners.”
Side not stated
  • Ted KrammManagementconfirmed
    “LUX Infusion's aim is to remove the friction that's often associated with infusion therapy," said Ted Kramm, Chief Executive Officer of LUX Infusion.”

Evidence

“LUX Infusion Acquires Be Well Memory and Infusion's Specialty Infusion Business”
Press releaseconfidence 80%recorded Nov 3, 2026